On Wednesday, January 11, 2023 at 10:00 AM ET, CRG LLC is holding an auction for Rubius Therapeutics. Rubius Therapeutics is a biopharmaceutical company focused on developing a new class of medicines known as Red Cell Therapeutics™. These therapies are designed to use genetically modified red blood cells as a delivery mechanism for a variety of therapeutic proteins, including enzymes, hormones, and other bioactive molecules.
The auction features a range of laboratory, manufacturing, and office equipment, including: Sartorius AMBR 250 BioReactor System, Sartorius AMBR 15 Cell Culture BioReactor, Sartorius Biostat STR-50 Single Use BioReactors, Eppendorf/Das Gip BioReactor Systems, AB Sciex 4500 Triple Quad Mass Spec, GE/Cytiva AKTA Avant 150 Chromatography Systems, BD FACSAria Fusion, Infors Triple Stack Incubators, GE AKTA Start Protein Purification System, Miltenyi CliniMACS, Beckman Coulter Vi-Cell Analyzers, Agilent HPLC, Freezers & Incubators, and BioSafety Cabinets.
CRG LLC is a leading provider of asset management and disposition services for the biotech, pharmaceutical, and life science industries. The company has a long history of successfully managing complex asset divestitures and has a team of industry experts who are well-versed in the unique needs of these industries.
For further information about this, or any other CRG LLC. auction, please visit: